News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
645,199 Results
Type
Article (61281)
Company Profile (70)
Press Release (583848)
Multimedia
Podcasts (59)
Webinars (13)
Section
Business (173762)
Career Advice (2729)
Deals (32424)
Drug Delivery (97)
Drug Development (76921)
Employer Resources (150)
FDA (14937)
Job Trends (13882)
News (305014)
Policy (28945)
Tag
Academia (2893)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (88)
Alliances (43199)
ALS (88)
Alzheimer's disease (1321)
Antibody-drug conjugate (ADC) (109)
Approvals (14953)
Artificial intelligence (264)
Autoimmune disease (23)
Automation (15)
Bankruptcy (290)
Best Places to Work (10856)
BIOSECURE Act (16)
Biosimilars (101)
Biotechnology (52)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (273)
Cancer (2182)
Cardiovascular disease (166)
Career advice (2312)
Career pathing (33)
CAR-T (154)
Cell therapy (429)
Cervical cancer (20)
Clinical research (62562)
Collaboration (785)
Company closure (1)
Compensation (326)
Complete response letters (21)
COVID-19 (2571)
CRISPR (43)
C-suite (260)
Cystic fibrosis (100)
Data (2153)
Decentralized trials (2)
Denatured (25)
Depression (43)
Diabetes (254)
Diagnostics (6157)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (114)
Drug pricing (97)
Drug shortages (23)
Duchenne muscular dystrophy (86)
Earnings (60152)
Editorial (39)
Employer branding (18)
Employer resources (132)
Events (94510)
Executive appointments (761)
FDA (16194)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (748)
Gene editing (109)
Generative AI (20)
Gene therapy (299)
GLP-1 (666)
Government (4459)
Grass and pollen (6)
Guidances (65)
Healthcare (18208)
Huntington's disease (19)
IgA nephropathy (25)
Immunology and inflammation (108)
Indications (29)
Infectious disease (2704)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (96)
Interviews (526)
IPO (14793)
IRA (38)
Job creations (3413)
Job search strategy (1941)
Kidney cancer (10)
Labor market (30)
Layoffs (503)
Leadership (22)
Legal (6439)
Liver cancer (69)
Lung cancer (304)
Lymphoma (145)
Machine learning (7)
Management (53)
Manufacturing (276)
MASH (63)
Medical device (12660)
Medtech (12665)
Mergers & acquisitions (18211)
Metabolic disorders (637)
Multiple sclerosis (78)
NASH (13)
Neurodegenerative disease (84)
Neuropsychiatric disorders (26)
Neuroscience (1839)
NextGen: Class of 2025 (6373)
Non-profit (4316)
Now hiring (12)
Obesity (324)
Opinion (232)
Ovarian cancer (71)
Pain (91)
Pancreatic cancer (79)
Parkinson's disease (142)
Partnered (21)
Patents (234)
Patient recruitment (112)
Peanut (50)
People (59559)
Pharmaceutical (20)
Pharmacy benefit managers (15)
Phase I (19674)
Phase II (27601)
Phase III (20168)
Pipeline (1143)
Policy (125)
Postmarket research (2476)
Preclinical (8399)
Press Release (67)
Prostate cancer (107)
Psychedelics (27)
Radiopharmaceuticals (250)
Rare diseases (360)
Real estate (5991)
Recruiting (61)
Regulatory (20102)
Reports (33)
Research institute (2396)
Resumes & cover letters (405)
Rett syndrome (5)
RNA editing (3)
RSV (35)
Schizophrenia (68)
Series A (132)
Series B (86)
Service/supplier (9)
Sickle cell disease (51)
Special edition (10)
Spinal muscular atrophy (146)
Sponsored (29)
Startups (3342)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (26)
The Weekly (32)
Vaccines (668)
Venture capitalists (34)
Weight loss (204)
Women's health (30)
Worklife (19)
Date
Last 7 days (816)
Last 30 days (2355)
Last 365 days (30385)
2025 (10173)
2024 (32306)
2023 (36372)
2022 (46655)
2021 (51598)
2020 (50725)
2019 (44775)
2018 (34072)
2017 (30768)
2016 (30096)
2015 (35471)
2014 (28430)
2013 (24991)
2012 (26247)
2011 (26482)
2010 (24962)
Location
Africa (872)
Alabama (54)
Alaska (6)
Arizona (171)
Arkansas (14)
Asia (38059)
Australia (6849)
California (5556)
Canada (1847)
China (487)
Colorado (248)
Connecticut (259)
Delaware (140)
Europe (89201)
Florida (848)
Georgia (199)
Idaho (56)
Illinois (548)
India (25)
Indiana (279)
Iowa (10)
Japan (153)
Kansas (95)
Kentucky (24)
Louisiana (10)
Maine (61)
Maryland (828)
Massachusetts (4018)
Michigan (222)
Minnesota (338)
Mississippi (2)
Missouri (87)
Montana (29)
Nebraska (23)
Nevada (58)
New Hampshire (61)
New Jersey (1640)
New Mexico (29)
New York (1629)
North Carolina (957)
North Dakota (9)
Northern California (2407)
Ohio (194)
Oklahoma (15)
Oregon (36)
Pennsylvania (1234)
Puerto Rico (12)
Rhode Island (31)
South America (1177)
South Carolina (17)
South Dakota (1)
Southern California (2126)
Tennessee (95)
Texas (848)
United States (21244)
Utah (172)
Virginia (143)
Washington D.C. (50)
Washington State (511)
West Virginia (3)
Wisconsin (60)
645,199 Results for "university of copenhagen".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
News
OpRegen® (RG6501) Phase 1/2a Results to Be Featured at International Society for Stem Cell Research (ISSCR) 2024 Copenhagen International Symposium
September 25, 2024
·
7 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Press Releases
Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery
April 23, 2025
·
6 min read
Press Releases
BioPorto announces completion of an oversubscribed directed offering of 25 million new shares raising DKK 33.5 million
April 28, 2025
·
2 min read
Press Releases
AAVantgarde appoints Mr. Rasmus Holm-Jorgensen as Chief Financial Officer
April 29, 2025
·
2 min read
Biomica CSO to Present at the ECCO 2023 Annual Meeting in Copenhagen between March 1-4, 2023
Biomica, a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), today announced it will be presenting at the 2023 ECCO Annual Meeting taking place in Copenhagen, Denmark from March 1 to 4, 2023.
March 1, 2023
·
3 min read
Lone Star Bio
FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
FibroBiologics, Inc. announced that Chief Scientific Officer, Hamid Khoja, Ph.D., will present on FibroBiologics’ wound care and psoriasis programs at the Extracellular Matrix (ECM) Pharmacology Congress in Copenhagen, Denmark, from June 17-19, 2024.
June 6, 2024
·
5 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Biotech Bay
Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark
Mainz Biomed NV, a leading molecular genetics diagnostic company focused on early cancer detection, announced its participation in the upcoming UEG Week.
October 11, 2023
·
5 min read
Biotech Bay
Turn Biotechnologies Co-Founder to Present at Prestigious ARDD Meeting in Copenhagen
Turn Biotechnologies co-founder Vittorio Sebastiano will share company data during a presentation on the potential of epigenetic reprogramming to increase human longevity during this week’s 10th Aging Research and Drug Discovery Meeting, the world’s largest longevity forum.
August 28, 2023
·
2 min read
1 of 64,520
Next
